Applied BioCode, Inc. Licenses Barcoded Magnetic Bead Technology And BioCode MDx 3000 High Throughput MDx System To PerkinElmer, Inc. For Asian Infectious Disease Markets

SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--Applied BioCode announced today that it has expanded its existing License and Supply Agreement for its multiplex Barcoded Magnetic Bead (BMB) technology with PerkinElmer. The non-exclusive license from Applied BioCode provides PerkinElmer with access to Applied BioCode’s 4,096-plex BMB patents and BioCode MDx 3000 high throughput system for the Asian markets. PerkinElmer will develop market specific multiplexed molecular diagnostics infectious disease assays for the BioCode MDx 3000 system and distribute these products into select markets in Asia.

Help employers find you! Check out all the jobs and post your resume.